News

Your contact person

Manager PR & Communications Jan Phillip Denkers

The surgical team prepares for an upcoming operation. — The 5-person SurgMark team has already developed several surgical and wound healing products and achieved approvals as Class III medical devices in the U.S. and Europe – and is now on the verge of FDA approval with SchurSign®. (Image: © stock.adobe.com/Syda Productions)

03.05.2023 Medtech start-up SurgMark aims to enter the US market

In breast imaging, doctors mark suspicious areas with marker clips. With SchurSign®, the Hamburg-based medical technology start-up SurgMark has developed an innovative tissue marker made ...

04.04.2022 MAGIA: new collaboration agreement with China

MAGIA, the Medtech Alliance for Global InternationAlisation to market, announces it has joined forces with SCIMEA (Sichuan international medical exchange and promotion association, China) to ...

There are the signatures! On behalf of Life Science Nord, Managing Director Dr. Hinrich Habeck (top row center) signed the Memorandum of Understanding during a ceremony via web conference.

23.03.2022 New connections Between Japan and Europe

On Tuesday, March 22, 2022, MAGIA, the Medtech Alliance for Global InternationAlisation to market, announces it has joined forces with FBRI (Foundation for Biomedical Research ...

1
2